Key facts
- This page summarizes Philip A. Fain's Form 4 filing for ULTRALIFE CORP (ULBI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Apr 2024, 15:26.
Philip A. Fain - 17 Apr 2024 Form 4 Insider Report for ULTRALIFE CORP (ULBI)
- Reporting relationship
- CFO and Treasurer
- Issuer ticker
- ULBI
- Reported as of
- 17 Apr 2024
- Net transaction value
- +$40,974
- SEC form
- 4
- Accepted by SEC
- 19 Apr 2024, 15:26:55 UTC
- Prior SEC filing
- 11 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Philip Fain
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Philip A. Fain filed Form 4 for ULTRALIFE CORP (ULBI) on 19 Apr 2024.
Change
- Previous filing in this sequence was filed on 11 Dec 2023.
- Current net transaction value: +$40,974.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ULBI
transaction
Common Stock; $.10 par value
Options Exercise
- Transaction value
- $40,974
- Shares
- +7,179
- Change %
- +5.5%
- Price
- $5.71
- Shares after
- 137,809
- Date
- 17 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ULBI
transaction
Derivative
Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $5.71
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
(1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 12,821 shares of common stock, retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long Term Incentive Plan, in payment of the exercise price for the options.
Footnote F2
(2) Represents exercise of options for 20,000 shares of common stock of the Company.